Celadon Pharmaceuticals
PublicCeladon Pharmaceuticals is now publicly traded
The data on this page reflects Celadon Pharmaceuticals's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Mar 28, 2022
Last Round
Debt
Jun 11, 2025
Total Funding Raised
$18.54M
Company Overview
Celadon Pharmaceuticals is a pharmaceutical company that engages in the research, cultivation, manufacturing, and supply of cannabinoid-based medicines for the chronic pain market.
AI Layer
Non-AI
Keywords
Celadon Pharmaceuticals Comparables
Compare Celadon Pharmaceuticals with similar companies based on industry and business-model similarity.
No public comparables are available for Celadon Pharmaceuticals. Request access to learn about comparables coverage.
Request accessCeladon Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jun 11, 2025 | ||||
| Private Placement | Sep 11, 2024 | ||||
| Private Placement | May 10, 2024 | ||||
| Private Placement | Dec 12, 2023 | ||||
| IPO | Mar 28, 2022 |
Celadon Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seneca Partners | IPO |
Celadon Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access